Skip to main content
Official Website of Stem Cell Mexico – Since 2002
Stem Cell Therapy Mexico

Can Stem Cell Therapy cure Stroke patient?

No. Stem cell therapy does not cure stroke, and no current treatment can fully replace the brain tissue lost when blood flow was interrupted.

Free Consultation
Brain location on a neutral human figure

What mesenchymal stem cells (MSCs) can offer is support for recovery: they release anti-inflammatory and neuroprotective signals that may help the surviving brain adapt, and some patients report gains in movement, balance, speech, energy or daily function, especially when treatment is combined with rehabilitation. A Cochrane systematic review of randomized trials in ischemic stroke found that stem cell transplantation was associated with reduced neurological impairment, with no significant safety concerns. At Stem Cell Mexico, stroke protocols use only allogeneic MSCs from Wharton's jelly of the umbilical cord, usually by intravenous (IV) infusion and, in selected cases after the doctor reviews your medical reports, by an additional intrathecal application. Treatment complements rehabilitation and stroke prevention, results vary between patients, and stroke plans typically cost $7,000 to $9,500 USD.

This guide explains why stroke damage cannot be fully reversed, how recovery happens, what regenerative treatment can support and how to set goals that matter.

What happens in a stroke

A stroke occurs when blood flow to part of the brain is blocked (ischemic stroke, the most common type) or when a blood vessel bursts (hemorrhagic stroke). Without oxygen, brain cells in the affected area die within minutes to hours. According to the World Stroke Organization, stroke is one of the leading causes of death and long-term disability worldwide.

The effects depend on the area of the brain involved:

  • Weakness or paralysis on one side of the body.
  • Speech and language problems (aphasia).
  • Balance and coordination problems.
  • Vision loss in part of the visual field.
  • Memory, attention and thinking changes.
  • Fatigue, mood changes and spasticity.

Why stroke cannot be cured

Brain cells lost in the core of a stroke are not replaced, and the adult brain has limited ability to generate new neurons. What makes recovery possible is neuroplasticity: surviving areas take over lost functions, new connections form and existing pathways become more efficient with practice. Most natural recovery happens in the first three to six months, but meaningful gains can continue for years with continued rehabilitation.

This is why the goal of stroke care, including regenerative treatment, is to maximize recovery and prevent another stroke, rather than to reverse the damage completely.

What MSCs can support

MSCs from Wharton's jelly act through paracrine signaling, releasing factors that may:

  • Reduce inflammation in the brain after stroke.
  • Protect surviving neurons in the areas around the injury.
  • Promote new blood vessel formation.
  • Support neuroplasticity, which may make rehabilitation more productive.
  • Modulate the immune system.

Patients and families sometimes describe improvements in hand or leg movement, walking and balance, speech, fatigue, spasticity or mood. These changes, when they occur, are usually gradual and vary widely.

What the evidence shows

  • Cochrane systematic review (2019): analyzed seven randomized trials with 401 participants with ischemic stroke who received different types of stem cells. Stem cell transplantation was associated with reduced neurological impairment, and no significant safety concerns were identified regarding mortality or adverse events.
  • MASTERS trial: a randomized, double-blind, placebo-controlled trial in The Lancet Neurology found that an IV bone-marrow-derived cell product was safe and well tolerated after acute ischemic stroke, with exploratory signals of benefit when given early.
  • Safety of umbilical cord MSCs: a 2026 meta-analysis of IV umbilical-cord-derived MSCs in Stem Cells Translational Medicine found temporary fever as the most consistent side effect, without an increase in serious infection, thrombosis, cancer or death in controlled trials.

Realistic goals after stroke

For people in the chronic phase, the most valuable changes are often specific:

  • Better grip or hand opening for daily tasks.
  • Steadier walking or fewer falls.
  • Clearer speech or easier word finding.
  • Less spasticity in the arm or leg.
  • More energy for therapy and daily life.
  • Greater independence in dressing, eating or bathing.

Defining two or three goals like these with the doctor and your therapists makes it possible to measure change. Standard tools, such as strength testing, walking speed, hand function tests and independence scales, recorded before treatment and at three and six months, show clearly what improved. Family members are often the first to notice small changes in daily routines, and their observations are a valuable part of the picture.

Rehabilitation and prevention remain essential

Rehabilitation, including physical, occupational and speech therapy, is the foundation of stroke recovery. Preventing another stroke is equally important: blood pressure control, cholesterol management, treatment of atrial fibrillation, diabetes control, not smoking and regular physical activity. Regenerative treatment is added to this care, and no stroke prevention medication should be stopped because of it.

What our patients usually receive

Based on the treatment plans our team prepares for neurological patients, a typical stroke protocol at Stem Cell Mexico includes:

  • Wharton's jelly MSCs by IV infusion, usually between 100 and 200 million cells, depending on body weight and medical review.
  • An additional intrathecal application (similar to an epidural, usually about 60 million cells) in selected cases, after the doctor reviews your medical reports and confirms you are a candidate.
  • One night at our facilities, sometimes two, with nursing and medical monitoring and fall prevention measures.
  • Consultation with your doctor and the stem cell specialist, pre-treatment laboratory tests and ground transportation from the San Diego airport area, with wheelchair accessibility when needed.

Stroke plans typically cost $7,000 to $9,500 USD. Recovery is gradual, and each person responds differently: some notice changes within the first weeks, while others notice them over the following months. Our team stays in contact after treatment to follow your progress and decide whether a second application could help.

Timing: when is treatment considered?

Most patients we see are in the chronic phase, months or years after their stroke, when they have completed initial rehabilitation and want to support further progress. Treatment is not given during the acute phase, when emergency care, clot-dissolving treatment or thrombectomy and hospital monitoring are the priorities. If you or someone near you shows signs of a new stroke, such as sudden facial drooping, arm weakness or speech difficulty, call emergency services immediately.

Safety considerations after stroke

  • Blood thinners and antiplatelet drugs are continued and reviewed by the doctor.
  • Blood pressure is checked before and after treatment.
  • Fall prevention is part of every stay, with help for walking and transfers in an unfamiliar environment.
  • Fever can temporarily make weakness feel worse; it is monitored and treated promptly.

No treatment is free of risk, which is why screening and monitoring are adapted to each patient.

Preparing for the visit

  • Bring your records: brain imaging reports, neurology and rehabilitation notes, and a list of medications with doses.
  • Record a baseline: ask your therapists for recent scores, such as strength, walking speed, hand function or speech tests, and record short videos of walking and hand use.
  • Plan support: request airport wheelchair assistance if needed and travel with a companion.
  • Continue medications, including blood thinners and blood pressure medications, unless the doctor indicates otherwise.
  • Plan rehabilitation for the months after treatment, ideally with more intensive sessions.

Questions families often ask

Is it too late if the stroke happened years ago? Not necessarily. Many people in the chronic phase seek treatment to support further progress, and goals are adapted to their situation.

Will speech improve? Some patients and families report clearer speech or easier word finding, usually alongside speech therapy. Results vary, and speech is best measured by a speech therapist before and after treatment.

Can it prevent another stroke? No. Prevention depends on blood pressure control, medications, healthy habits and management of conditions such as atrial fibrillation.

Who may be a candidate

  • Ischemic or hemorrhagic stroke, usually at least several months earlier, with stable medical condition.
  • Controlled blood pressure and stroke prevention measures in place.
  • No active infection and no cancer within the past five years.
  • Participation in rehabilitation before and after treatment, with goals agreed with your therapists.

Questions to ask during your evaluation

  • What changes could be realistic for my type of stroke and time since it happened?
  • Am I a candidate for the intrathecal application?
  • How will my blood thinners and blood pressure medications be managed during the visit and afterward?
  • How will we measure results with my therapists?

Bottom line

Stem cell therapy does not cure stroke, but Wharton's jelly MSCs can support recovery through anti-inflammatory and neuroprotective signals, with a favorable safety record and reduced neurological impairment reported in a Cochrane review of randomized trials. At Stem Cell Mexico, treatment complements rehabilitation and stroke prevention, and results vary between patients. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your recovery, goals and medical history.

References

  1. Cochrane: Boncoraglio GB et al. Stem cell transplantation for ischemic stroke, 2019 (opens in a new tab)
  2. Hess DC et al. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Neurology, 2017 (opens in a new tab)
  3. World Stroke Organization (WSO): Global Stroke Fact Sheet (opens in a new tab)
  4. Hum C et al. Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis. Stem Cells Translational Medicine, 2026 (opens in a new tab)

Request your medical evaluation

A clearer path starts here.

Tell us a little about yourself. We’ll help you understand the next step.

Vania, patient coordinator at Stem Cell Mexico

Vania, our patient coordinator

Your questions. Your travel plans.
A real person to help.

Talk to Vania on WhatsApp (opens in a new tab)

What happens next?

  1. Your advisor contacts you.
  2. We explain the medical review.
  3. You explore your options.

Call +1 800 646 0290

Let’s begin with you.

Your inquiry starts a conversation. Treatment requires medical evaluation.

Vania · Patient Advisor

Start my free evaluation
Free Consultation